Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome)
The systemic capillary leak syndrome (SCLS) is a rare disorder characterized by transient episodes of hypotensive shock and anasarca thought to arise from reversible microvascular barrier dysfunction. Although the high prevalence of a monoclonal gammopathy of unknown significance in SCLS suggests a...
Uloženo v:
| Vydáno v: | Blood Ročník 119; číslo 18; s. 4321 |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
03.05.2012
|
| Témata: | |
| ISSN: | 1528-0020, 1528-0020 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The systemic capillary leak syndrome (SCLS) is a rare disorder characterized by transient episodes of hypotensive shock and anasarca thought to arise from reversible microvascular barrier dysfunction. Although the high prevalence of a monoclonal gammopathy of unknown significance in SCLS suggests a pathogenic contribution of endogenous immunoglobulins, the mechanisms of vascular hyperpermeability remain obscure. Herein, we report clinical and molecular findings on 23 patients, the largest SCLS case series to date. Application of episodic SCLS sera, but neither the purified immunoglobulin fraction nor sera obtained from patients during remission, to human microvascular endothelial cells caused vascular endothelial cadherin internalization, disruption of interendothelial junctions, actin stress fiber formation, and increased permeability in complementary functional assays without inducing endothelial apoptosis. Intravenous immunoglobulin, one promising therapy for SCLS, mitigated the permeability effects of episodic sera. Consistent with the presence of endogenous, nonimmunoglobulin, circulating permeability factor(s) constrained to SCLS episodes, we found that vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2), were elevated in episodic SCLS sera but not in remission sera. Ab-based inhibition of Ang2 counteracted permeability induced by episodic SCLS sera. Comparable experiments with anti-VEGF Ab (bevacizumab) yielded less interpretable results, probably because of endothelial toxicity of VEGF withdrawal. Our results support a model of SCLS pathogenesis in which nonimmunoglobulin humoral factors such as VEGF and Ang2 contribute to transient endothelial contraction, suggesting a molecular mechanism for this highly lethal disorder. |
|---|---|
| AbstractList | The systemic capillary leak syndrome (SCLS) is a rare disorder characterized by transient episodes of hypotensive shock and anasarca thought to arise from reversible microvascular barrier dysfunction. Although the high prevalence of a monoclonal gammopathy of unknown significance in SCLS suggests a pathogenic contribution of endogenous immunoglobulins, the mechanisms of vascular hyperpermeability remain obscure. Herein, we report clinical and molecular findings on 23 patients, the largest SCLS case series to date. Application of episodic SCLS sera, but neither the purified immunoglobulin fraction nor sera obtained from patients during remission, to human microvascular endothelial cells caused vascular endothelial cadherin internalization, disruption of interendothelial junctions, actin stress fiber formation, and increased permeability in complementary functional assays without inducing endothelial apoptosis. Intravenous immunoglobulin, one promising therapy for SCLS, mitigated the permeability effects of episodic sera. Consistent with the presence of endogenous, nonimmunoglobulin, circulating permeability factor(s) constrained to SCLS episodes, we found that vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2), were elevated in episodic SCLS sera but not in remission sera. Ab-based inhibition of Ang2 counteracted permeability induced by episodic SCLS sera. Comparable experiments with anti-VEGF Ab (bevacizumab) yielded less interpretable results, probably because of endothelial toxicity of VEGF withdrawal. Our results support a model of SCLS pathogenesis in which nonimmunoglobulin humoral factors such as VEGF and Ang2 contribute to transient endothelial contraction, suggesting a molecular mechanism for this highly lethal disorder. The systemic capillary leak syndrome (SCLS) is a rare disorder characterized by transient episodes of hypotensive shock and anasarca thought to arise from reversible microvascular barrier dysfunction. Although the high prevalence of a monoclonal gammopathy of unknown significance in SCLS suggests a pathogenic contribution of endogenous immunoglobulins, the mechanisms of vascular hyperpermeability remain obscure. Herein, we report clinical and molecular findings on 23 patients, the largest SCLS case series to date. Application of episodic SCLS sera, but neither the purified immunoglobulin fraction nor sera obtained from patients during remission, to human microvascular endothelial cells caused vascular endothelial cadherin internalization, disruption of interendothelial junctions, actin stress fiber formation, and increased permeability in complementary functional assays without inducing endothelial apoptosis. Intravenous immunoglobulin, one promising therapy for SCLS, mitigated the permeability effects of episodic sera. Consistent with the presence of endogenous, nonimmunoglobulin, circulating permeability factor(s) constrained to SCLS episodes, we found that vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2), were elevated in episodic SCLS sera but not in remission sera. Ab-based inhibition of Ang2 counteracted permeability induced by episodic SCLS sera. Comparable experiments with anti-VEGF Ab (bevacizumab) yielded less interpretable results, probably because of endothelial toxicity of VEGF withdrawal. Our results support a model of SCLS pathogenesis in which nonimmunoglobulin humoral factors such as VEGF and Ang2 contribute to transient endothelial contraction, suggesting a molecular mechanism for this highly lethal disorder.The systemic capillary leak syndrome (SCLS) is a rare disorder characterized by transient episodes of hypotensive shock and anasarca thought to arise from reversible microvascular barrier dysfunction. Although the high prevalence of a monoclonal gammopathy of unknown significance in SCLS suggests a pathogenic contribution of endogenous immunoglobulins, the mechanisms of vascular hyperpermeability remain obscure. Herein, we report clinical and molecular findings on 23 patients, the largest SCLS case series to date. Application of episodic SCLS sera, but neither the purified immunoglobulin fraction nor sera obtained from patients during remission, to human microvascular endothelial cells caused vascular endothelial cadherin internalization, disruption of interendothelial junctions, actin stress fiber formation, and increased permeability in complementary functional assays without inducing endothelial apoptosis. Intravenous immunoglobulin, one promising therapy for SCLS, mitigated the permeability effects of episodic sera. Consistent with the presence of endogenous, nonimmunoglobulin, circulating permeability factor(s) constrained to SCLS episodes, we found that vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2), were elevated in episodic SCLS sera but not in remission sera. Ab-based inhibition of Ang2 counteracted permeability induced by episodic SCLS sera. Comparable experiments with anti-VEGF Ab (bevacizumab) yielded less interpretable results, probably because of endothelial toxicity of VEGF withdrawal. Our results support a model of SCLS pathogenesis in which nonimmunoglobulin humoral factors such as VEGF and Ang2 contribute to transient endothelial contraction, suggesting a molecular mechanism for this highly lethal disorder. |
| Author | Jones, Nina Nelson, Celeste Greipp, Philip R Druey, Kirk M Iwaki, Shoko Ghosh, Chandra C Gaskins, Donna Patel, Roshni Parikh, Samir M Xie, Zhihui |
| Author_xml | – sequence: 1 givenname: Zhihui surname: Xie fullname: Xie, Zhihui organization: Molecular Signal Transduction Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA – sequence: 2 givenname: Chandra C surname: Ghosh fullname: Ghosh, Chandra C – sequence: 3 givenname: Roshni surname: Patel fullname: Patel, Roshni – sequence: 4 givenname: Shoko surname: Iwaki fullname: Iwaki, Shoko – sequence: 5 givenname: Donna surname: Gaskins fullname: Gaskins, Donna – sequence: 6 givenname: Celeste surname: Nelson fullname: Nelson, Celeste – sequence: 7 givenname: Nina surname: Jones fullname: Jones, Nina – sequence: 8 givenname: Philip R surname: Greipp fullname: Greipp, Philip R – sequence: 9 givenname: Samir M surname: Parikh fullname: Parikh, Samir M – sequence: 10 givenname: Kirk M surname: Druey fullname: Druey, Kirk M |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22411873$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNkElLBDEQhYOMOIv-A5Ecx0Nrll6PMrjBgJfB65BOKkycLG2n-9An_7oRRxAKqnh8vHq8JZr54AGha0ruKK3ZfWtDUBkjlGakznhV1LQ8QwtasDojhJHZv3uOljF-EEJzzooLNGcsTx4VX6CvdxHlaEWPwaswHMAaYfFh6qBP40C0xpphwsarUULEicDSGm9kwuLkuiG4iIPGm-RxjMFjZSKICHj9g8YpDuCMxFJ0xiZkwhbEMele9cHB7SU618JGuDrtFdo9Pe42L9n27fl187DNZN7wIeNQVBVwVVKldUFzrXkJZVNSoHkl2kKWkJeaNg2vNGuqPBFSQaFbXUvJWrZC61_brg-fI8Rh70yUkBJ5CGPc01QjbdIrntCbEzq2DtS-641Lufd_nbFv41p04Q |
| CitedBy_id | crossref_primary_10_1186_s13023_019_1263_6 crossref_primary_10_1016_j_revmed_2014_11_005 crossref_primary_10_1007_s10238_021_00693_0 crossref_primary_10_1371_journal_pone_0133266 crossref_primary_10_1136_bcr_2017_221068 crossref_primary_10_1371_journal_pone_0251775 crossref_primary_10_1097_SHK_0000000000001254 crossref_primary_10_1093_ehjcr_ytaa013 crossref_primary_10_1111_all_12862 crossref_primary_10_3389_fimmu_2021_641427 crossref_primary_10_1111_ped_14345 crossref_primary_10_3389_fmed_2018_00111 crossref_primary_10_1002_ccr3_3811 crossref_primary_10_1111_jcmm_14381 crossref_primary_10_1007_s11739_019_02113_4 crossref_primary_10_1186_1471_2431_14_137 crossref_primary_10_1002_ccr3_280 crossref_primary_10_1186_s12967_022_03587_1 crossref_primary_10_1097_SHK_0b013e31829f91fc crossref_primary_10_1053_j_jvca_2015_02_016 crossref_primary_10_1016_j_ccc_2019_12_003 crossref_primary_10_1007_s12185_020_03011_8 crossref_primary_10_1093_ehjcr_ytac262 crossref_primary_10_1007_s40620_025_02250_4 crossref_primary_10_1016_j_jcrpr_2016_09_004 crossref_primary_10_3390_biomedicines13010008 crossref_primary_10_3389_fimmu_2020_535147 crossref_primary_10_1111_imj_12271 crossref_primary_10_1016_j_annder_2020_04_021 crossref_primary_10_1016_j_critrevonc_2016_09_004 crossref_primary_10_1136_bcr_2019_232500 crossref_primary_10_1155_2021_8098942 crossref_primary_10_1007_s00108_018_0409_2 crossref_primary_10_1213_XAA_0000000000000808 crossref_primary_10_1002_JLB_5A0817_324R crossref_primary_10_1097_INF_0000000000000029 crossref_primary_10_1161_CIRCRESAHA_122_322332 crossref_primary_10_36290_vnl_2019_078 crossref_primary_10_1111_bjh_15644 crossref_primary_10_1016_j_kint_2019_03_001 crossref_primary_10_1016_j_biopha_2024_116147 crossref_primary_10_1111_joim_13641 crossref_primary_10_1007_s00018_017_2624_8 crossref_primary_10_1016_j_jaci_2016_10_042 crossref_primary_10_1089_ct_2020_32_450_453 crossref_primary_10_1016_j_amjmed_2017_05_023 crossref_primary_10_1159_000533957 crossref_primary_10_1007_s40487_024_00263_w crossref_primary_10_1186_s40001_024_01738_2 crossref_primary_10_1016_j_yexcr_2013_03_011 crossref_primary_10_1096_fj_201802052RRR crossref_primary_10_1016_j_amsu_2021_103013 crossref_primary_10_1016_j_ajem_2014_11_057 crossref_primary_10_3390_jcm10225415 crossref_primary_10_1016_j_jaip_2017_07_021 crossref_primary_10_4081_btvb_2025_152 crossref_primary_10_1016_j_kint_2016_11_029 crossref_primary_10_3389_fmed_2019_00089 crossref_primary_10_1186_s40635_023_00582_8 crossref_primary_10_1164_rccm_201301_0136LE crossref_primary_10_1172_JCI180795 crossref_primary_10_1007_s11739_025_03890_x crossref_primary_10_1172_JCI169137 crossref_primary_10_1186_s12879_025_10699_8 crossref_primary_10_3390_jcm8020143 crossref_primary_10_1161_ATVBAHA_124_321522 crossref_primary_10_1080_17843286_2020_1792685 crossref_primary_10_1136_bcr_2022_253045 crossref_primary_10_1136_bcr_2018_226108 crossref_primary_10_3389_fimmu_2022_1050994 crossref_primary_10_1177_23993693231176883 crossref_primary_10_1016_j_hrtlng_2018_04_008 crossref_primary_10_1038_s41409_022_01874_5 crossref_primary_10_3390_diagnostics14171924 crossref_primary_10_1186_s12887_019_1401_2 crossref_primary_10_3390_jcm14061871 crossref_primary_10_1038_s41572_024_00571_5 crossref_primary_10_3389_fgene_2023_1282711 crossref_primary_10_2217_imt_2020_0335 crossref_primary_10_1111_jdv_13847 crossref_primary_10_1111_tbj_12866 crossref_primary_10_1111_petr_12831 crossref_primary_10_1097_AAP_0000000000000302 crossref_primary_10_1111_ddg_15336 crossref_primary_10_1038_s41598_020_59269_9 crossref_primary_10_1016_j_medcli_2020_05_056 crossref_primary_10_1097_MD_0000000000000591 crossref_primary_10_1016_j_anndiagpath_2022_152028 crossref_primary_10_7759_cureus_77261 crossref_primary_10_3390_jcm11030623 crossref_primary_10_7759_cureus_38335 crossref_primary_10_1038_nrd_2016_278 crossref_primary_10_1186_s12968_015_0181_6 crossref_primary_10_1513_AnnalsATS_202411_1214CC crossref_primary_10_1007_s10456_021_09769_7 crossref_primary_10_1073_pnas_1519467113 crossref_primary_10_1007_s10456_016_9537_2 crossref_primary_10_1213_XAA_0000000000001537 crossref_primary_10_7759_cureus_14370 crossref_primary_10_1080_14779072_2018_1456920 crossref_primary_10_1155_2015_958283 crossref_primary_10_3201_eid2710_211155 crossref_primary_10_1007_s10875_019_00722_4 crossref_primary_10_1016_j_semarthrit_2016_08_001 crossref_primary_10_1097_MD_0000000000002648 crossref_primary_10_1515_bj_2015_0019 crossref_primary_10_1038_s42003_019_0647_4 crossref_primary_10_1186_s41100_021_00371_7 crossref_primary_10_1590_abd1806_4841_20175994 crossref_primary_10_1186_s13054_023_04496_5 crossref_primary_10_1016_j_revmed_2021_03_325 crossref_primary_10_1007_s11897_023_00618_w crossref_primary_10_1161_CIRCHEARTFAILURE_119_006097 crossref_primary_10_1016_j_revmed_2021_05_012 crossref_primary_10_1016_j_jaci_2018_09_001 crossref_primary_10_1016_j_medcle_2021_07_004 crossref_primary_10_3390_biomedicines10102379 crossref_primary_10_1089_cmb_2019_0222 crossref_primary_10_1161_CIRCRESAHA_116_306534 crossref_primary_10_3390_biomedicines10061221 crossref_primary_10_1111_bjh_20193 crossref_primary_10_1038_nm_4057 crossref_primary_10_1177_08850666231193955 crossref_primary_10_1097_MD_0000000000010716 crossref_primary_10_1016_j_accpm_2015_05_003 crossref_primary_10_3389_fimmu_2024_1403376 crossref_primary_10_12998_wjcc_v9_i33_10273 crossref_primary_10_3389_fimmu_2022_1045002 crossref_primary_10_1111_cea_13506 crossref_primary_10_1111_ddg_15336_g crossref_primary_10_1016_j_neuroscience_2019_07_044 crossref_primary_10_1016_S2665_9913_21_00348_9 crossref_primary_10_1586_1744666X_2014_882771 crossref_primary_10_3389_fphar_2023_1242970 crossref_primary_10_1186_s13256_016_0894_7 crossref_primary_10_1002_ajum_12320 crossref_primary_10_1016_j_anai_2017_02_013 crossref_primary_10_1084_jem_20162143 crossref_primary_10_3390_jcm7110418 crossref_primary_10_1164_rccm_201310_1746LE crossref_primary_10_1007_s12254_021_00789_z |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1182/blood-2011-08-375816 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology Anatomy & Physiology |
| EISSN | 1528-0020 |
| ExternalDocumentID | 22411873 |
| Genre | Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: Intramural NIH HHS – fundername: NHLBI NIH HHS grantid: R01HL093234-01S1 – fundername: NIAID NIH HHS grantid: AI001083 – fundername: NIDDK NIH HHS grantid: K08DK06916 – fundername: NHLBI NIH HHS grantid: R01HL093234 – fundername: NHLBI NIH HHS grantid: R01 HL093234 |
| GroupedDBID | --- -~X .55 0R~ 23N 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6J9 AAEDW AALRI AAXUO ABOCM ACGFO ADBBV ADVLN AENEX AFOSN AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BTFSW CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD EX3 F5P FDB FRP GS5 GX1 H13 IH2 K-O KQ8 L7B LSO MJL N9A NPM OK1 P2P R.V RHF RHI ROL SJN THE TR2 TWZ W2D W8F WH7 WOQ WOW X7M YHG YKV 7X8 ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP EFKBS |
| ID | FETCH-LOGICAL-c493t-3e577e3d61dff514ff36e6961e147ab5c6e46f19937f297414fcde5fbf8cc2b2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 156 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000305284600030&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1528-0020 |
| IngestDate | Sun Sep 28 00:26:01 EDT 2025 Wed Feb 19 02:30:28 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 18 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c493t-3e577e3d61dff514ff36e6961e147ab5c6e46f19937f297414fcde5fbf8cc2b2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://dx.doi.org/10.1182/blood-2011-08-375816 |
| PMID | 22411873 |
| PQID | 1011194933 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1011194933 pubmed_primary_22411873 |
| PublicationCentury | 2000 |
| PublicationDate | 2012-05-03 |
| PublicationDateYYYYMMDD | 2012-05-03 |
| PublicationDate_xml | – month: 05 year: 2012 text: 2012-05-03 day: 03 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Blood |
| PublicationTitleAlternate | Blood |
| PublicationYear | 2012 |
| SSID | ssj0014325 |
| Score | 2.4677198 |
| Snippet | The systemic capillary leak syndrome (SCLS) is a rare disorder characterized by transient episodes of hypotensive shock and anasarca thought to arise from... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 4321 |
| SubjectTerms | Acute Disease Adherens Junctions - drug effects Adherens Junctions - ultrastructure Adult Aged Angiopoietin-2 - antagonists & inhibitors Angiopoietin-2 - blood Antibodies, Monoclonal, Humanized - pharmacology Apoptosis - drug effects Bevacizumab Capillary Leak Syndrome - blood Capillary Leak Syndrome - etiology Capillary Leak Syndrome - physiopathology Capillary Permeability Cells, Cultured - drug effects Chronic Disease Convalescence Cytoskeleton - ultrastructure Endothelial Cells - drug effects Endothelium, Vascular - physiopathology Female Humans Immunoglobulins, Intravenous - therapeutic use Male Middle Aged Paraproteinemias - blood Paraproteinemias - complications Recombinant Proteins - pharmacology Vascular Endothelial Growth Factor A - antagonists & inhibitors Vascular Endothelial Growth Factor A - blood Vascular Endothelial Growth Factor A - genetics Vascular Endothelial Growth Factor A - pharmacology |
| Title | Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome) |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/22411873 https://www.proquest.com/docview/1011194933 |
| Volume | 119 |
| WOSCitedRecordID | wos000305284600030&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB5868VHfb8YQUQPQfLaJCfRYvFgiweR3kKyDyzapDYq9ORfd3azsSdBEELIYfPcye43M9_OB3DKaBoXIiDvJMlCJwhyTQKIMscNZRhkrqdiw3Z_uo96vbjfTx5swK2ytMpmTDQDtSi5jpHT301_ZRKQ_301enO0apTOrloJjVmY9wnKaEpX1J9mEQLfiK7SFBU7GhfZpXMEqS9rWvhPgJBQs8t-B5lmsums_fcx12HVwky8ru1iA2Zk0YLN64Jc7OEEz9AQP01EvQWLN83RcruRf2vBUtdm3Tfh68nSVVEWQq_YeiWjxWfyYMe0DWVd6nuC5N6ToVRILbBZcYnVZDiim1ZYKjRkIAL4aNNCeK6b1sWkBxx5NtIaSOMJvsrsBZtiChdb8Ni5fWzfOVa4weH05u-OL8Mokr5grlCKEJlSPpMsYa50gyjLQ85kwJSmDkbKI4eGWnAhQ5WrmHMv97ZhrigLuQsotCZaEiuhpQNlKAivCEYTqCLcxwnr7MFJ0w0pfR-d7MgKWX5U6bQj9mCn7st0VBfwSDVsoQv6-384-wBWyEo8w3H0D2Fe0aggj2CBf74PqvGxMTja9x66355G4PM |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vascular+endothelial+hyperpermeability+induces+the+clinical+symptoms+of+Clarkson+disease+%28the+systemic+capillary+leak+syndrome%29&rft.jtitle=Blood&rft.au=Xie%2C+Zhihui&rft.au=Ghosh%2C+Chandra+C&rft.au=Patel%2C+Roshni&rft.au=Iwaki%2C+Shoko&rft.date=2012-05-03&rft.issn=1528-0020&rft.eissn=1528-0020&rft.volume=119&rft.issue=18&rft.spage=4321&rft_id=info:doi/10.1182%2Fblood-2011-08-375816&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-0020&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-0020&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-0020&client=summon |